Rapport Therapeutics, Inc.
RAPP
$38.08
$0.842.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -107.28M | -111.48M | -97.70M | -88.31M | -79.70M |
| Total Depreciation and Amortization | 1.00M | 1.02M | 1.01M | 975.00K | 931.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.81M | 19.49M | 18.23M | 14.11M | 11.01M |
| Change in Net Operating Assets | 3.17M | 3.50M | 1.24M | -2.94M | 308.00K |
| Cash from Operations | -80.30M | -87.47M | -77.22M | -76.17M | -67.45M |
| Capital Expenditure | -411.00K | -616.00K | -673.00K | -679.00K | -1.62M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -170.15M | -186.86M | 19.45M | 23.20M | -105.56M |
| Cash from Investing | -170.56M | -187.47M | 18.78M | 22.52M | -107.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 271.59M | 270.79M | 270.48M | 13.00K | 159.11M |
| Repurchase of Common Stock | -5.00K | -1.00K | -1.00K | -1.40M | -1.40M |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -29.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -273.00K | 0.00 | 0.00 | -63.00K | 283.00K |
| Cash from Financing | 271.31M | 270.79M | 270.48M | -1.45M | 157.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.45M | -4.16M | 212.05M | -55.10M | -16.66M |